Low Incidence of Off-Target Mutations in Individual CRISPR-Cas9 and TALEN Targeted Human Stem Cell Clones Detected by Whole-Genome Sequencing

Veres, Adrian, Gosis, Bridget S., Ding, Qiurong, Collins, Ryan, Ragavendran, Ashok, Brand, Harrison, Erdin, Serkan, Cowan, Chad A. +2 more·2014·Cell Stem Cell

Cited by (474)

Items 301–400 of 474

  1. Responsible governance of human germline genome editing in China
    Yaojin Peng, Jianwei Lv, Lulu Ding, Xia Gong, Qi Zhou · 2022 · Biology of Reproduction
  2. CRISPR-ON-Mediated KLF4 overexpression inhibits the proliferation, migration and invasion of urothelial bladder cancer in vitro and in vivo
    Xin Xu, Jiangfeng Li, Yi Zhu, Bo Xie, Xiao Wang, Song Wang, Haiyun Xie, Huaqing Yan, Yufan Ying, Yiwei Lin et al. · 2017 · Oncotarget
  3. The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation and modulates translation and splicing
    Andrea Stoehr, Leslie Kennedy, Yanqin Yang, Sajni Patel, Yongshun Lin, Kaari L. Linask, Marı́a M. Fergusson, Jun Zhu, Marjan Guček, Jizhong Zou et al. · 2019 · JCI Insight
  4. Gene surgery
    Ayman El-Meghawry El-Kenawy, Bachir Benarba, Adriana Freitas Neves, Thaise Gonçalves Araújo, Bee Ling Tan, Adel Gouri · 2019 · EXCLI journal
  5. Deciphering Common Long QT Syndrome Using CRISPR/Cas9 in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Yongfei Song, Zequn Zheng, Jiangfang Lian · 2022 · Frontiers in Cardiovascular Medicine
  6. Emergence of CRISPR/Cas9-mediated bioimaging: A new dawn of in-situ detection
    Tian Meng, Rui Zhang, Jinming Li · 2023 · Biosensors and Bioelectronics
  7. Salient Features of Endonuclease Platforms for Therapeutic Genome Editing
    Michael T. Certo, Richard A. Morgan · 2016 · Molecular Therapy
  8. The application of CRISPR technology to high content screening in primary neurons
    Ben L. Callif, Brian Maunze, Nick L. Krueger, Matthew T. Simpson, Murray G. Blackmore · 2017 · Molecular and Cellular Neuroscience
  9. Gene therapy for hemoglobin disorders - a mini-review
    Punam Malik · 2016 · Journal of Rare Diseases Research & Treatment
  10. Directed evolution of λ integrase activity and specificity by genetic derepression
    Jia Wei Siau, Sharon Min Qi Chee, Harshyaa Makhija, Cho Mar Myint Wai, Shree Harsha Vijaya Chandra, Sabrina Peter, Peter Dröge, Farid John Ghadessy · 2015 · Protein Engineering Design and Selection
  11. Research on genodermatoses using novel genome‐editing tools
    Janin Lehmann, Christina Seebode, Steffen Emmert · 2017 · JDDG Journal der Deutschen Dermatologischen Gesellschaft
  12. CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING
    Galaxy Y. Cho, Kellie A. Schaefer, Alexander G. Bassuk, Stephen H. Tsang, Vinit B. Mahajan · 2018 · Retina
  13. CRISPR delivery systems for organ-specific targeting: Advances and challenges
    Jun Du, Qinjie Wu, Chao Liu, Ning Wang, Changyang Gong · 2025 · Precision medicine and engineering.
  14. When Extinction Is Warranted: Invasive Species, Suppression-Drives and the Worst-Case Scenario
    Ann C. Thresher · 2020 · Ethics Policy & Environment
  15. Delivery challenges for CRISPR—Cas9 genome editing for Duchenne muscular dystrophy
    Made Harumi Padmaswari, Shilpi Agrawal, Mary S. Jia, Allie Ivy, Daniel A. Maxenberger, Landon A. Burcham, Christopher E. Nelson · 2023 · Biophysics Reviews
  16. Applications of the CRISPR/Cas9 system in murine cancer modeling
    Marc Zuckermann, Daisuke Kawauchi, Jan Gronych · 2016 · Briefings in Functional Genomics
  17. Aspects of Gene Therapy Products Using Current Genome-Editing Technology in Japan
    Teruhide Yamaguchi, Eriko Uchida, Takashi Okada, Keiya Ozawa, Masafumi Onodera, Akihiro Kume, Takashi Shimada, Satoru Takahashi, Kenzaburo Tani, Yasutomo Nasu et al. · 2020 · Human Gene Therapy
  18. A Cell-Based Optimised Approach for Rapid and Efficient Gene Editing of Human Pluripotent Stem Cells
    Sara Cuevas Ocaña, Jin Ye Yang, Magomet Aushev, George Schlossmacher, Christine E. Bear, Nicholas R. F. Hannan, Neil D. Perkins, Janet Rossant, Amy P. Wong, Michael A. Gray · 2023 · International Journal of Molecular Sciences
  19. A calibrated cell‐based functional assay to aid classification of MLH1 DNA mismatch repair gene variants
    Abhijit Rath, Alexander A. Radecki, Kaussar Rahman, Rachel B. Gilmore, Jonathan R. Hudson, Matthew Cenci, Sean V. Tavtigian, James P. Grady, Christopher D. Heinen · 2022 · Human Mutation
  20. Utility of CRISPR/Cas9 systems in hematology research
    Daniel Lucas, Heather A. O’Leary, Benjamin L. Ebert, Chad A. Cowan, Cedric Stevens Tremblay · 2017 · Experimental Hematology
  21. Efficient and Specific Generation of MSTN-Edited Hu Sheep Using C-CRISPR
    Rihong Guo, Huili Wang, Chunhua Meng, Hongbing Gui, Yinxia Li, Fang Chen, Chenjian Zhang, Han Zhang, Qiang Ding, Jianli Zhang et al. · 2023 · Genes
  22. Applications of Functional Genomics for Drug Discovery
    Ami M. Kabadi, Eoin McDonnell, Christopher L. Frank, Lauren Drowley · 2020 · SLAS DISCOVERY
  23. Highly efficient generation of GGTA1 knockout pigs using a combination of TALEN mRNA and magnetic beads with somatic cell nuclear transfer
    Chong Feng, Xirui Li, Huiting Cui, Chuan Long, Xia Liu, Xing-hua TIAN, Dengke Pan, Yuzhu Luo · 2016 · Journal of Integrative Agriculture
  24. CRISPR-Cas9 and He Jiankui's Case: an Islamic Bioethics Review using Maqasid al-Shari'a and Qawaid Fighiyyah
    Nimah Alsomali, Ghaiath Hussein · 2021 · Asian Bioethics Review
  25. The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes
    Fuga Takahashi, Praneel Patel, Takahiro Kitsuka, Kenichi Arai · 2023 · Bioengineering
  26. TALEN‐mediated gene editing of the thrombospondin‐1 locus in axolotl
    Tzu‐Hsing Kuo, Johanna E. Kowalko, Tia DiTommaso, Mandi Nyambi, Daniel T. Montoro, Jeffrey J. Essner, Jessica L. Whited · 2015 · Regeneration
  27. Regenerative medicine: targeted genome editing in vivo
    Lixia Wang, Jun Wu, Weiwei Fang, Guang‐Hui Liu, Juan Carlos Izpisúa Belmonte · 2015 · Cell Research
  28. T cell-specific inactivation of mouse CD2 by CRISPR/Cas9
    Jane Beil-Wagner, Georg Dössinger, Kilian Schober, Johannes vom Berg, Achim Tresch, Martina Grandl, Pushpalatha Palle, Florian Mair, Markus Gerhard, Burkhard Becher et al. · 2016 · Scientific Reports
  29. Modification of the Genome of Domestic Animals
    Samantha N. Lotti, Kathryn M. Polkoff, M. Rubessa, Matthew B. Wheeler · 2017 · Animal Biotechnology
  30. Conditional gene knockout and reconstitution in human iPSCs with an inducible Cas9 system
    Mengyao Wu, Senquan Liu, Yongxing Gao, Hao Bai, Vasiliki Machairaki, Gang Li, Tong Chen, Linzhao Cheng · 2018 · Stem Cell Research
  31. Homology-independent multiallelic disruption via CRISPR/Cas9-based knock-in yields distinct functional outcomes in human cells
    Chenzi Zhang, Xijing He, Yvonne K. Y. Kwok, Feng Wang, Junyi Xue, Hui Zhao, Kin Wah Suen, Chi Chiu Wang, Jianwei Ren, George G. Chen et al. · 2018 · BMC Biology
  32. European Court of Justice decision for genome editing: Consequences on food/feed risk assessment and detection
    Hermann Broll, Albert Braeuning, Alfonso Lampen · 2019 · Food Control
  33. CRISPR/Cas9-mediated Inactivation of arginase in a yeast strain isolated from Nuruk and its impact on the whole genome
    Young‐Wook Chin, Seung Chul Shin, Suk Han, Hae Won Jang, Hyo Jin Kim · 2021 · Journal of Biotechnology
  34. Comprehensive Analysis of CRISPR/Cas9-Mediated Mutagenesis in Arabidopsis thaliana by Genome-Wide Sequencing
    W. Xu, Wei Fu, Pengyu Zhu, Zhihong Li, Chenguang Wang, Chaonan Wang, Yongjiang Zhang, Shuifang Zhu · 2019 · International Journal of Molecular Sciences
  35. The experimental design and data interpretation in “Unexpected mutations after CRISPR–Cas9 editing in vivo ” by Schaefer et al. are insufficient to support the conclusions drawn by the authors
    Christopher J. Wilson, Tim J. Fennell, Anne Bothmer, Morgan L. Maeder, Deepak Reyon, Cecilia Cotta‐Ramusino, Cecilia A. Fernández, Eugenio Marco, Luis Alberto Barrera, Hariharan Jayaram et al. · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
  36. A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
    Shaina N. Porter, Rachel M. Levine, Shondra M. Pruett‐Miller · 2019 · Comprehensive physiology
  37. Genome-edited human stem cell-derived beta cells: a powerful tool for drilling down on type 2 diabetes GWAS biology
    Nicola L. Beer, Anna L. Gloyn · 2016 · F1000Research
  38. Generating universal chimeric antigen receptor expressing cell products from induced pluripotent stem cells: beyond the autologous CAR-T cells
    Xinyue L. Deng, Jianfeng Zhou, Yang Cao · 2023 · Chinese Medical Journal
  39. CRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical Application
    Bettina E. Bernard, Emmanuelle Landmann, Lukas T. Jeker, Kathrin Schumann · 2022 · Immunology Letters
  40. SDF ‐1‐edited human amniotic mesenchymal stem cells stimulate angiogenesis in treating hindlimb ischaemia
    Hong Zhe Zhang, Seong-Ho Han, Sung‐Whan Kim · 2022 · Journal of Cellular and Molecular Medicine
  41. Genome Editing in Human Pluripotent Stem Cells
    Cory J. Smith, Zhaohui Ye, Linzhao Cheng · 2016 · Cold Spring Harbor Protocols
  42. Research and Therapeutic Approaches in Stem Cell Genome Editing by CRISPR Toolkit
    Behrouz Mollashahi, Hamid Latifi‐Navid, Iman Owliaee, Sara Shamdani, Georges Uzan, Saleh Jamehdor, Sina Naserian · 2023 · Molecules
  43. CRISPR/Cas9: The Leading Edge of Genome Editing Technology
    Tetsushi Sakuma, Takashi Yamamoto · 2014 · Springer eBooks
  44. Acquisition of chromosome 1q duplication in parental and genome‐edited human‐induced pluripotent stem cell‐derived neural stem cells results in their higher proliferation rate in vitro and in vivo
    Narges Zare Mehrjardi, Marek Molčányi, Firuze Fulya Hatay, Marco Timmer, Ebrahim Shahbazi, Justus P. Ackermann, Stefan Herms, Stefanie Heilmann‐Heimbach, Thomas F. Wunderlich, Nora Prochnow et al. · 2020 · Cell Proliferation
  45. SeqCor: correct the effect of guide RNA sequences in clustered regularly interspaced short palindromic repeats/Cas9 screening by machine learning algorithm
    Xiaojian Liu, Yuanyuan Yang, Yan Qiu, Md. Reyad‐ul‐Ferdous, Qiurong Ding, Yi Wang · 2020 · Journal of genetics and genomics/Journal of Genetics and Genomics
  46. Genome Editing Human Pluripotent Stem Cells to Model β-Cell Disease and Unmask Novel Genetic Modifiers
    Matthew N. George, Karla F. Leavens, Paul J. Gadue · 2021 · Frontiers in Endocrinology
  47. Whole Genome Sequencing Analysis of Effects of CRISPR/Cas9 in Komagataella phaffii: A Budding Yeast in Distress
    Veronika Schusterbauer, Jasmin Elgin Fischer, Sarah Gangl, Lisa Schenzle, Claudia Rinnofner, Martina Geier, Christian Sailer, Anton Glieder, Gerhard Thallinger · 2022 · Journal of Fungi
  48. Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders
    Valentina Buffa, José Roberto Alvarez Vargas, Anne H. M. Galy, Simone Spinozzi, Céline J. Rocca · 2023 · Frontiers in Genome Editing
  49. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Associated Proteins (Cas) [CRISPR–Cas]: An Emerging Technique in Plant Disease Detection and Management
    Swapan K. Ghosh, Tuhin Chatterjee · 2024 · Springer eBooks
  50. Identifying functional noncoding variants from genome-wide association studies for cardiovascular disease and related traits
    Andrew J P Smith, Steve Eric Humphries, Philippa J. Talmud · 2015 · Current Opinion in Lipidology
  51. Increasing the precision of gene editing in vitro, ex vivo, and in vivo
    Katherine P. Mueller, Jared Carlson-Stevermer, Krishanu Saha · 2018 · Current Opinion in Biomedical Engineering
  52. Convergence of human pluripotent stem cell, organoid, and genome editing technologies
    Lin Wang, Zhaohui Ye, Yoon-Young Jang · 2021 · Experimental Biology and Medicine
  53. CRISPR-Cas9 System as a Genome Editing Tool in Sugarcane
    Sruthy Maria Augustine · 2017 · Springer eBooks
  54. Tracking CRISPR’s Footprints
    Lin Lin, Yonglun Luo · 2019 · Methods in molecular biology
  55. Discovering the Genome-Wide Activity of CRISPR-Cas Nucleases
    Shengdar Q. Tsai · 2017 · ACS Chemical Biology
  56. The therapeutic potential of genome editing for β-thalassemia
    Astrid Glaser, Bradley McColl, Jim Vadolas · 2015 · F1000Research
  57. CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells
    Markus Mandl, Heike Ritthammer, Asim Ejaz, Sonja Wagner, Florian M. Hatzmann, Saphira Baumgarten, Hans P. Viertler, Marit Zwierzina, Monika Mattesich, Valerie Schiller et al. · 2020 · Adipocyte
  58. An Episomal CRISPR/Cas12a System for Mediating Efficient Gene Editing
    Nannan Duan, Shuqing Tang, Baitao Zeng, Zhiqing Hu, Qian Hu, Lingqian Wu, Miaojin Zhou, Desheng Liang · 2021 · Life
  59. Reprogramming cells with synthetic proteins
    Ralf Jauch, Xiaoxiao Yang, Vikas Malik · 2014 · Asian Journal of Andrology
  60. CRISPR/Cas9-Mediated Mutagenesis of Human Pluripotent Stem Cells in Defined Xeno-Free E8 Medium
    Chew-Li Soh, Danwei Huangfu · 2016 · Methods in molecular biology
  61. No excessive mutations in transcription activator-like effector nuclease-mediated α-1,3-galactosyltransferase knockout Yucatan miniature pigs
    Kimyung Choi, Joohyun Shim, Nayoung Ko, Joonghoon Park · 2019 · Asian-Australasian Journal of Animal Sciences
  62. DGK and DZHK position paper on genome editing: basic science applications and future perspective
    Ralf Peter Brandes, Anne Dueck, Stefan Hanns Engelhardt, Manuel Kaulich, Christian Kupatt, Maria Teresa De Angelis, Matthias S. Leisegang, Ferdinand A. C. le Noble, Alessandra Moretti, Oliver Josef Müller et al. · 2021 · Basic Research in Cardiology
  63. Genome- and cell-based strategies in therapy of muscular dystrophies
    Yara Bou Saada, Carla Dib, Marc Lipinski, Yegor S Vassetzky · 2016 · Biochemistry (Moscow)
  64. CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human iPSCs for Gene Therapy of Hemophilia B
    Qiyu Tang, Zhiqing Hu, Junya Zhao, Tao Zhou, Shuqing Tang, Peiyun Wang, Rou Xiao, Yan Chen, Lingqian Wu, Miaojin Zhou et al. · 2023 · International Journal of Molecular Sciences
  65. CRISPR technology in human diseases
    Qiang Feng, Qirong Li, Hengzong Zhou, Zhan Wang, Chao Lin, Ziping Jiang, Tianjia Liu, Dongxu Wang · 2024 · MedComm
  66. Recent advances in therapeutic recruitment of mammalian RNAi and bacterial CRISPR-Cas DNA interference pathways as emerging antiviral strategies
    Wei-Xin Chin, Swee Kim Ang, Justin Jang Hann Chu · 2016 · Drug Discovery Today
  67. Whole-Genome Sequencing Reveals Rare Off-Target Mutations in MC1R -Edited Pigs Generated by Using CRISPR-Cas9 and Somatic Cell Nuclear Transfer
    Zhenyang Li, Jin Lan, Xuan Shi, Tong Lu, Xiaoli Hu, Xiaohong Liu, Yaosheng Chen, Zuyong He · 2024 · The CRISPR Journal
  68. Novel stem cell technologies are powerful tools to understand the impact of human factors on Plasmodium falciparum malaria
    Alena Pance, Bee Ling Ng, Kioko Mwikali, Manousos Koutsourakis, Chukwuma A. Agu, Foad J. Rouhani, Ruddy Montandon, Frances Law, Hannes Ponstingl, Julian C. Rayner · 2023 · Frontiers in Cellular and Infection Microbiology
  69. CRISPR-Cas9 editing of synaptic genes in human embryonic stem cells for functional analysis in induced human neurons
    Aiden Houcek, Zhenzhong Ma, Brent Trauterman, Burak Uzay, Lisa M. Monteggia, Ege T. Kavalali · 2024 · STAR Protocols
  70. CRISPR/Cas9 and TALE: beyond cut and paste
    Liping Deng, Ruotong Ren, Jun Wu, Keiichiro Suzuki, Juan Carlos Izpisúa Belmonte, Guang‐Hui Liu · 2015 · Protein & Cell
  71. The genome editing revolution: A CRISPR-Cas TALE off-target story
    Stefano Stella, Guillermo Montoya · 2015 · Inside the Cell
  72. Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders
    Daniela Benati, Amy Leung, Pedro R.L. Perdigão, Vasileios Toulis, Jacqueline van der Spuy, Alessandra Recchia · 2022 · International Journal of Molecular Sciences
  73. Gene Editing of the Follicle-Stimulating Hormone Gene to Sterilize Channel Catfish, Ictalurus punctatus, Using a Modified Transcription Activator-like Effector Nuclease Technology with Electroporation
    Guyu Tracy Qin, Zhenkui Qin, Cuiyu Lu, Zhi Ye, Ahmed Elaswad, Yulin Jin, Mohd Golam Quader Khan, Baofeng Su, Rex A. Dunham · 2023 · Biology
  74. SeqVerify: An accessible analysis tool for cell line genomic integrity, contamination, and gene editing outcomes
    Merrick Pierson Smela, Valerio Pepe, Steven J Lubbe, Evangelos Kiskinis, George McDonald Church · 2024 · Stem Cell Reports
  75. Computational and molecular tools for scalable rAAV-mediated genome editing
    Ivaylo Stoimenov, Muhammad Akhtar Ali, Tatjana Pandzic, Tobias Sjöblom · 2014 · Nucleic Acids Research
  76. Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease
    Haojie Yu, Chad A. Cowan · 2016 · Molecular Endocrinology
  77. TATA box-binding protein-related factor 3 drives the mesendoderm specification of human embryonic stem cells by globally interacting with the TATA box of key mesendodermal genes
    Liang He, Peng Zhang, Huajun Bai, Jijun Huang, Huang‐Tian Yang · 2020 · Stem Cell Research & Therapy
  78. Beyond precision: evaluation of off-target clustered regularly interspaced short palindromic repeats/Cas9–mediated genome editing
    Irene Peña-Gutiérrez, Beatriz Olalla-Sastre, Paula Rı́o, Juan R. Rodríguez-Madoz · 2024 · Cytotherapy
  79. Application of human induced pluripotent stem cells to model fibrodysplasia ossificans progressiva
    Emilie Barruet, Edward Chiaming Hsiao · 2017 · Bone
  80. Efficient Production of Biallelic RAG1 Knockout Mouse Embryonic Stem Cell Using CRISPR/Cas9
    Maryam Mehravar, Abolfazl Shirazi, Mohammad Mehdi Mehrazar, Mahboobeh Nazari, Mehdi Banan, Maryam Salimi · 2019 · Iranian Journal of Biotechnology
  81. Therapeutic Gene Editing with CRISPR
    Elan Hahn, Matthew Hiemenz · 2020 · Clinics in Laboratory Medicine
  82. Induced Pluripotent Stem Cells in Regenerative Medicine
    Luna Simona Pane, Ilaria My, Alessandra Moretti · 2016 · Springer eBooks
  83. Deriving rabbit embryonic stem cells by small molecule inhibitors.
    Jiao Liu, Xiumei Zhu, Jinshan Li, Zhihui Liu, Yanhong Liu, Fei Xue, Lan Yang, Liyou An, Chien-Hong Chen, Giorgio Antonio Presicce et al. · 2019 · Europe PMC (PubMed Central)
  84. Rescue of the disease-associated phenotype in CRISPR-corrected hiPSCs as a therapeutic approach for inherited retinal dystrophies
    Siles, Laura, Pomares, Esther · 2025 · Molecular Therapy Nucleic Acids
  85. A Practical Guide to Genome Editing Using Targeted Nuclease Technologies
    Shaina N. Porter, Rachel M. Levine, S. Pruett-Miller · 2019 · Comprehensive Physiology
  86. No obvious unintended effects was found in gene editing rice through transcriptional and proteomic analysis
    Liu Xiao-Jing, Xing Bao, Wang Meng-Yu, Xiaoman Li, Xujing Wang, Zhixing Wang · 2023 · GM crops & food
  87. Selected Innovative Solutions for the Regulation of GM Crops in Times of Gene Editing
    Klaus Ammann · 2019 · Springer eBooks
  88. Extensive humoral immune response to AAVs and Cas proteins in nonhuman primates
    Puhao Xiao, Raoxian Bai, Ting Zhang, Yin Zhou, Zhigang Zhou, Yan Zhuo, Nannan Gong, Yuyu Niu, Shuaiwei Ren, Ruo Wu et al. · 2021 · 中国科学通报:英文版
  89. Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA
    Lisa M. Smith, Jason T. Ladner, Vida L. Hodara, Laura M. Parodi, R. Alan Harris, Jessica E. Callery, Zhao Lai, Yi Zou, Muthuswamy Raveedran, Jeffrey Rogers et al. · 2021 · Journal of Virology
  90. A roadmap for neurodevelopmental disease modeling for non-stem cell biologists
    Carl Ernst · 2020 · Stem Cells Translational Medicine
  91. Genome Editing with Targetable Nucleases
    S. William Pelletier · 2016 · Springer eBooks
  92. Combining CRISPR/Cas9-Mediated Knockout with Genetic Complementation for in-Depth Mechanistic Studies in Human ES cells
    Zheng Wang, Yan Zhang, Yu-Wei Lee, Natalia B. Ivanova · 2019 · BioTechniques
  93. Novel Assay Analyzing Tropism between Adipose-Derived Stem Cells and Breast Cancer Cells Reveals a Low Oncogenic Response
    Matthias A. Sauter, Elizabeth Anne Brett, Christina M. Müller, Hans‐Günther Machens, Dominik Duscher · 2019 · Breast Care
  94. A CRISPR/Cas9 based strategy to manipulate the Alzheimer’s amyloid pathway
    Jichao Sun, Jared Carlson-Stevermer, Utpal Das, Minjie Shen, Marion Delenclos, Amanda M. Snead, Lina Wang, Jonathan Loi, Andrew J. Petersen, Michael E. Stockton et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  95. STEM CELL TECHNOLOGY PROVIDES NOVEL TOOLS TO UNDERSTAND HUMAN VARIATION IN Plasmodium falciparum MALARIA
    Alena Pance, Bee Ling, Kioko Mwikali, Manousos Koutsourakis, Chukwuma A. Agu, Foad J. Rouhani, Hannes Ponstingl, Ruddy Montandon, Frances Law, Julian C. Rayner · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  96. CRISPR-Cas9 Mediated Gene Deletion in Human Pluripotent Stem Cells Cultured Under Feeder-Free Conditions
    Muhammad Abid Sheikh, Farah Afandi, Grazia Iannello, Barbara Corneo, Bright Starling Emerald, Suraiya Anjum Ansari · 2024 · Journal of Visualized Experiments
  97. Multi-omic Analyses Reveal Minimal Impact of the CRISPR-Cas9 Nuclease on Cultured Human Cells
    Jiali Qiang, Zaijun Ma, Xingxing Xie, Linyu Shi, Yang Geng, Junhao Hu, Rui Liu, Nan Liu, Yaoyang Zhang · 2019 · Journal of Proteome Research
  98. Molecular Switch Engineering for Precise Genome Editing
    Daisuke Matsumoto, Wataru Nomura · 2021 · Bioconjugate Chemistry
  99. Off-target effects in genome editing
    Igor Kovalchuk · 2021 · Elsevier eBooks
  100. CRISPR/Cas9 and piggyBac Transposon-Based Conversion of a Pathogenic Biallelic TBCD Variant in a Patient-Derived iPSC Line Allows Correction of PEBAT-Related Endophenotypes
    Valentina Muto, Federica Benigni, Valentina Magliocca, Rossella Borghi, Elisabetta Flex, Valentina Pallottini, Alessandro Rosa, Claudia Compagnucci, Marco Tartaglia · 2023 · International Journal of Molecular Sciences